AMANDA COLEMAN: Open Payments
NPI 1972249613 · ALBANY, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,431 in 42 payments from 17 companies in 2025. Trend: 2023 $2,962 · 2024 $1,161 · 2025 $1,431
Food & beverage: $1,431
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 5 | $392 |
| AngioDynamics, Inc. | 2 | $243 |
| UROGEN PHARMA, INC. | 5 | $208 |
| Ferring Pharmaceuticals Inc. | 7 | $122 |
| Sumitomo Pharma America, Inc. | 4 | $84 |
| Janssen Biotech, Inc. | 3 | $62 |
| PFIZER INC. | 3 | $57 |
| Antares Pharma, Inc. | 2 | $42 |
| Ethicon US, LLC | 2 | $38 |
| ABBVIE INC. | 2 | $36 |
Products named: NANOKNIFE, Axonics, JELMYTO, AMS 800 Artificial Urinary Sphincter, ADSTILADRIN, Xtandi, GEMTESA, ERLEADA.
Industry payments across GA — which companies pay providers there.
